PALLOTTA, MARIA TERESA
 Distribuzione geografica
Continente #
NA - Nord America 2.310
EU - Europa 2.062
AS - Asia 1.634
SA - Sud America 235
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 6.278
Nazione #
US - Stati Uniti d'America 2.251
SG - Singapore 692
IT - Italia 662
IE - Irlanda 278
HK - Hong Kong 274
CN - Cina 259
VN - Vietnam 234
BR - Brasile 191
DE - Germania 191
RO - Romania 165
FR - Francia 164
RU - Federazione Russa 145
FI - Finlandia 88
UA - Ucraina 82
GB - Regno Unito 64
SE - Svezia 63
KR - Corea 45
BE - Belgio 40
CZ - Repubblica Ceca 34
CA - Canada 31
IN - India 27
JP - Giappone 21
NL - Olanda 19
AR - Argentina 18
MX - Messico 18
PL - Polonia 15
TR - Turchia 15
CH - Svizzera 13
AT - Austria 11
BD - Bangladesh 10
ZA - Sudafrica 10
EC - Ecuador 9
ES - Italia 8
CI - Costa d'Avorio 7
ID - Indonesia 7
IQ - Iraq 7
VE - Venezuela 7
GR - Grecia 6
LT - Lituania 6
UZ - Uzbekistan 6
CO - Colombia 5
AE - Emirati Arabi Uniti 4
EU - Europa 4
MA - Marocco 4
AZ - Azerbaigian 3
IL - Israele 3
KZ - Kazakistan 3
LB - Libano 3
PK - Pakistan 3
TN - Tunisia 3
GT - Guatemala 2
IR - Iran 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CU - Cuba 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ML - Mali 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
PF - Polinesia Francese 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 6.278
Città #
Singapore 473
Perugia 391
Chandler 323
Dublin 278
Hong Kong 273
Dong Ket 167
Bucharest 155
Ashburn 144
San Mateo 136
Boardman 120
Santa Clara 97
Munich 90
Beijing 81
Redmond 77
Los Angeles 66
Wilmington 66
Medford 57
Princeton 56
Altamura 55
Ann Arbor 54
Moscow 44
Seoul 44
Lawrence 42
Brussels 40
Andover 37
Jacksonville 35
New York 32
Des Moines 27
Pisa 26
Dallas 23
Turku 23
Helsinki 22
Ho Chi Minh City 21
Falls Church 20
The Dalles 19
Chennai 18
Dearborn 18
Olomouc 18
Tokyo 18
Redwood City 17
Rome 17
Saint Petersburg 16
Brno 15
Chicago 15
Denver 14
West Jordan 14
Columbus 13
Montreal 13
Piscataway 13
Fremont 12
Norwalk 12
Nuremberg 12
Phoenix 12
San Paolo di Civitate 12
Warsaw 12
Enfield 11
Orem 11
Poplar 11
Stockholm 11
São Paulo 11
Chiajna 10
Izmir 10
Johannesburg 10
Milan 10
Atlanta 9
Brooklyn 9
Hefei 9
Houston 9
Lappeenranta 9
Terni 9
Woodbridge 9
Boston 8
Frankfurt am Main 8
Hanoi 8
Querétaro 8
San Jose 8
Abidjan 7
Bologna 7
Guangzhou 7
London 7
San Francisco 7
Toronto 7
Vicenza 7
Amsterdam 6
Haiphong 6
Manchester 6
Nanjing 6
Ottawa 6
San Diego 6
Seattle 6
Caracas 5
Curitiba 5
Hanover 5
Nürnberg 5
Tianjin 5
Athens 4
Buenos Aires 4
Mexico City 4
Paris 4
Quito 4
Totale 4.239
Nome #
Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1 204
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 189
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 175
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 165
Amino-acid sensing and degrading pathways in immune regulation 163
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 161
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 159
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 153
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 151
Amino acid metabolism as drug target in autoimmune diseases 149
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 143
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 130
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 127
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 127
LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism 124
88P - Relationship between functions and intracellular localization of the immune checkpoint target indoleamine 2, 3-dioxygenase 1 119
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 113
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 113
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 112
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 110
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 105
Different partners, opposite outcomes: A New Perspective of the Immunobiology of Indoleamine 2,3-Dioxygenase 103
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 103
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation 102
The TGF-β/IDO axis in infectious tolerance. 100
Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine 100
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 98
AhR-Mediated, Non-Genomic Modulation of IDO1 Function 98
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 95
Amino acid metabolism in rheumatoid arthritis: Friend or foe? 95
The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors 95
Unconventional Pathways of Protein Secretion: Mammals vs. Plants 92
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 92
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 89
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 88
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 87
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 86
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 84
CTLA-4-immunoglobulin and indoleamine 2,3 dioxygenase in dominant tolerance. 84
Extracellular Vesicles in Aging: An Emerging Hallmark? 83
Reinstalling immune regulatory tryptophan catabolism in juvenile diabetes via interleukin 6 receptor blockade 82
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 78
Human Indoleamine 2,3-dioxygenase 1 (IDO1) Expressed in Plant Cells Induces Kynurenine Production 77
IDO1 and TGF-β mediate protective effects of IFN-α in antigen-induced arthritis 76
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 71
Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity 71
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 70
Wolfram syndrome, a rare neurodegenerative disease: From pathogenesis to future treatment perspectives 70
Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme 69
Topical application of soluble CD83 induces IDO-mediated immune modulation, increases foxp3+ T cells, and prolongs allogeneic corneal graft survival 67
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 67
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 65
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells 64
Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3). 64
Unconventional Transport Routes of Soluble and Membrane Proteins and Their Role in Developmental Biology 63
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 62
FGF2 and IL-1β - explorers of unconventional secretory pathways at a glance 62
Sensing of an HIV-1-Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance 61
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 59
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 57
Moonlighting Proteins Are Important Players in Cancer Immunology 54
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 53
Vedere per credere: utilizzo della microscopia per lo studio dell’immunologia 51
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1 51
Western blot identification of NPM1 leukemic mutants in cytological AML samples: A powerful diagnostic technique 47
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 47
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 41
GLP-1 receptor agonists as promising disease-modifying agents in WFS1 spectrum disorder 38
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 38
Totale 6.541
Categoria #
all - tutte 27.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021335 0 0 0 0 0 22 40 20 40 23 18 172
2021/2022848 6 103 15 18 27 17 6 148 101 116 93 198
2022/20231.109 60 190 16 83 101 99 2 62 383 14 87 12
2023/2024605 26 69 21 13 8 11 158 18 42 35 65 139
2024/20251.283 21 97 56 106 122 87 104 138 208 69 168 107
2025/20261.442 164 180 165 362 386 185 0 0 0 0 0 0
Totale 6.541